2 completed, 1 withdrawn. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Pyridoxamine: new trials by email Literature Review of Pyridoxamine trials Research Report on Pyridoxamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes Pyridoxamine 300mg per day, Placebo 300mg placebo per day - Type 2 Diabetes, Microvascular Function | Not applicable | Completed | Maastricht University Medical Center | 40 | 2024-03-21 | 2026-04-27 |
| Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity Pyridoxamine, Placebo - Abdominal Obesity Metabolic Syndrome | Not applicable | Completed | Maastricht University Medical Center | 112 | 2016-10-14 | 2020-10-01 |
| A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria Pyridoxamine - Kidney Stones | Phase 2 | Withdrawn | University of Kansas Medical Center | 2007-01-01 | 2017-01-05 |
Abdominal obesity metabolic syndrome (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Diabetic Neuropathies (1) · Diabetic Retinopathy (1) · Kidney Calculi (1)
Maastricht University Medical Center (2) · University of Kansas Medical Center (1)
Netherlands (2)
Casper G Schalkwijk, PhD (1) · Jon I Scheinman, M.D. (1)
R21DK072454 (1)